This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As pharmaceutical reps are used less and less, the role of the MSL has become more prominent as a conduit between life sciences companies and external stakeholders for drug development.
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. They are no longer “just” educating and informing doctors but helping to accelerate medicalscience innovation.
This is particularly important due to the high value of an interaction between medicalscience liaisons (MSLs) and (key opinion leaders) KOLs. Elani Bowers, Medical Lead & Senior MedicalScience Liaison, Oncology, MSD ANZ spoke about this recently at the Veeva APAC Medical Community Forum.
Medicalscience Liaisons know that change is coming; How are they cashing in? Medicalscience liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.
Strengthening logistical capabilities One of the most unnecessary clinical trial burdens can be site inefficiencies, particularly where sites exist that do not recruit. Previously, he spent more than 10 years at Roche in multiple positions within medical affairs.
How To Find Clinical Sales Specialist Jobs At Rep-Lite, we’re shaking up the way the medical staffing and recruiting industry works. ” Networking and connecting with recruiters can also uncover opportunities. ” Networking and connecting with recruiters can also uncover opportunities.
which are currently recruiting patients. Hundreds of Israeli life science firms will be showing off their products and technologies to attendees from all over the world. Thanks to these designations, the firm is now preparing to commence a pivotal multi-center study with 20 sites around the U.S.,
Here is one of the entry-level resume examples you can use: Education: Bachelor of Science in Basic MedicalSciences (GPA: 3.8) The post Mastering the Art of Crafting an Impressive Entry-Level Resume: Your Gateway to Landing Your Dream Job appeared first on Medical Staffing & Recruitment Agency.
It’s hard to divvy all that because we work with medical affairs and medicalscience liaisons. In our role, we don’t have so much on the recruitment. In our direct team, there are thirteen FCE or Field Clinical Engineers. We have two managers. It’s such a broad team.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content